Purchases and Sales Made in Q4 2022 in Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV) during Q4 2022. The information is specifically focused on institutions that hold shares of Acrivon Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
4.81MNew |
N/A
|
4.81M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Perceptive Advisors LLC
New York, NY |
BUY
|
- |
3.01MNew |
N/A
|
3.01M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Sands Capital Ventures, LLC
Arlington, VA |
BUY
|
- |
1.65MNew |
N/A
|
1.65M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
1.63MNew |
N/A
|
1.63M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
1.22MNew |
N/A
|
1.22M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
BUY
|
- |
900KNew |
N/A
|
900K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
823KNew |
N/A
|
823K
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Nea Management Company, LLC
Timonium, MD |
BUY
|
- |
482KNew |
N/A
|
482K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Health Cor Management, L.P.
New York, NY |
BUY
|
- |
284KNew |
N/A
|
284K
$0
|
|
|
Feb 01, 2023
Q4 2022
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
42.4KNew |
N/A
|
42.4K
$0
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
38.8KNew |
N/A
|
38.8K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
38.8KNew |
N/A
|
38.8K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
21.5KNew |
N/A
|
21.5K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
19.6KNew |
N/A
|
19.6K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
BUY
|
- |
15.6KNew |
N/A
|
15.6K
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
4.75KNew |
N/A
|
4.75K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
4.14KNew |
N/A
|
4.14K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
869New |
N/A
|
869
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
159New |
N/A
|
159
$0
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|